Semler Announces FDA Clearance for Next Generation PAD Testing System
The next generation system features convenience and ease of use characteristics along with compatibility to electronic medical record systems for easy accessibility of data. The system was designed to fit the needs of Semler's growing customer base of insurance plans and integrated healthcare delivery networks. The clearance allows enhanced marketing labeling and messaging to describe the benefits of working with Semler's disease risk assessment tools.
The company expects to launch this next generation system later this year.
"It is our intention to make this Semler product the standard of care approach to diagnosing vascular disease," said
Peripheral artery disease (PAD) is a disease in which plaque or fatty deposits build up in the leg arteries limiting blood flow. Published studies have shown that persons with PAD are four times more likely to die of heart attack, and two-three times more likely to die of stroke, yet more than 50% of people with the disease are undiagnosed. Preventative healthcare like cessation of tobacco smoking and regular exercise may lower the risks associated with PAD.
This press release contains "forward-looking" statements. Such statements can be identified by, among other things, the use of forward-looking language such as the words "may," "will," "expect," "anticipate," "estimate," "project," "would," "could" or words with similar meaning or the negatives of these terms or by the discussion of strategy or intentions. The forward-looking statements in this release include statements regarding the timing of the launch of the next generation system, the ability of the new features to broaden appeal of the product and make it the standard of care, and whether or not the new system will be compatible with electronic medical record systems and meet the needs of the customer base, among others. Such forward-looking statements are subject to a number of risks and uncertainties that could cause
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/semler-announces-fda-clearance-for-next-generation-pad-testing-system-300052830.html
News Provided by Acquire Media